World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
97777
World Ranking
4250
National Ranking
164

Rafael Diaz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rafael Diaz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 297 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rafael Diaz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rafael Diaz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rafael Diaz is affiliated with the University of Alberta in Canada. Their research primarily intersects the field of Medicine with a focus on Cardiology and Cardiovascular Medicine, Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, and Public Health, Environmental and Occupational Health.

The scientist's main research topics cover areas related to Lipoproteins and Cardiovascular Health, Heart Failure Treatment and Management, Health Systems including Economic Evaluations and Quality of Life, Antiplatelet Therapy and Cardiovascular Diseases, Cardiovascular Function and Risk Factors, Pharmaceutical Economics and Policy, and the intersection of Diabetes, Cardiovascular Risks, and Lipoproteins.

Frequent publication venues for Rafael Diaz include:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • European Journal of Heart Failure
  • Diabetes Care

Frequent co-authors collaborating with Diaz comprise:

  • Deepak L. Bhatt
  • Philippe Gabríel Steg
  • Michael Szarek
  • J. Wouter Jukema
  • Vera Bittner

Selected recent papers authored or co-authored by Rafael Diaz include:

  • "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease," 2020, New England Journal of Medicine
  • "Rivaroxaban in Peripheral Artery Disease after Revascularization," 2020, New England Journal of Medicine
  • "Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial," 2022, The Lancet
  • "Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome," 2020, Journal of the American College of Cardiology
  • "Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study," 2020, The Lancet

Best Publications

  • Dabigatran versus warfarin in patients with atrial fibrillation

    Stuart J. Connolly;Michael D. Ezekowitz;John Eikelboom;Jonas Oldgren

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Apixaban in Patients with Atrial Fibrillation

    Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries

    Clara K. Chow;Clara K. Chow;Koon K. Teo;Sumathy Rangarajan;Shofiqul Islam

  • Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

    Martin J O'Donnell;Martin J O'Donnell;Siu Lim Chin;Sumathy Rangarajan;Denis Xavier

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

    Salim Yusuf;Philip Joseph;Sumathy Rangarajan;Shofiqul Islam

  • Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study

    Koon K Teo;Stephanie Ounpuu;Steven Hawken;Pandey

  • ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

    D Hunt;J Varigos;F Dienstl;P Lechleitner

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

    Sonia S. Anand;Sonia S. Anand;Sonia S. Anand;Shofiqul Islam;Shofiqul Islam;Shofiqul Islam;Annika Rosengren;Maria Grazia Franzosi

  • Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

    Mahshid Dehghan;Andrew Mente;Andrew Mente;Xiaohe Zhang;Sumathi Swaminathan

  • The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study

    Scott A Lear;Weihong Hu;Sumathy Rangarajan;Danijela Gasevic

  • Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

    Salim Yusuf;Shofiqul Islam;Clara K Chow;Sumathy Rangarajan

  • ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

    R Collins;R Peto;M Flather;S Parish

  • Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

    Salim Yusuf;Sumathy Rangarajan;Koon Teo;Shofiqul Islam

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Alvaro Avezum
Alvaro Avezum Population Health Research Institute
Patricio López-Jaramillo
Patricio López-Jaramillo University of Santander
Harvey D. White
Harvey D. White Auckland City Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Koon K. Teo
Koon K. Teo McMaster University
Annika Rosengren
Annika Rosengren Sahlgrenska University Hospital
Gilles R. Dagenais
Gilles R. Dagenais Université Laval
Shaun G. Goodman
Shaun G. Goodman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always mean attending medical school. There are a range of online degree programs designed for those seeking flexibility or exploring related healthcare roles. For registered nurses looking to advance, adn to np tracks provide a direct path to becoming a nurse practitioner, with bridge programs tailored for working professionals.

Nutrition is another key allied health field. The best online nutrition programs equip students to work in clinical, community, or research roles promoting health through diet.

If you’re interested in healthcare leadership, consider top online mha programs that are cahme accredited. These accredited Master of Healthcare Administration degrees prepare graduates for management positions in hospitals and health systems.

For registered nurses wanting to further their education without in-person requirements, there are online rn-bsn programs without clinicals. These programs let RNs earn a bachelor’s degree online, broadening their opportunities in the field.

Best Scientists Citing Rafael Diaz

Trending Scientists

Recently Published Articles